RESULTS:
A total of 55 devices (78% tissue expanders, 22% implants) in 43 patients underwent explantation during the study period. Reasons for explantation was infection (58%), patient request (22%), and wound related complications (20%). Of explants due to patient request, a contralateral explantation due to a complication was the most frequent reason (34%). Majority of explantations occurred after 30 days (62%), and after Stage I (81%). Median days to explantation was 62. No differences were observed when patient characteristics and surgical details were compared in early vs late explant groups. Older age (p=0.01) and high BMI (p=0.04) were found to be significant predictors of explantation for Stage I explantation when compared to Stage II. Among patients who underwent radiation, infection was the most common indication for device removal, with most explants occurring after adjuvant radiation therapy (64%). The most commonly cultured organisms were S.epidermidis (n=6, 10.9%), S.Aureus (n=6, 10.9%) and P.aeruginosa (n=6, 10.9%). Antibiotic resistance was commonly encountered for ampicillin, cefazolin, penicillin, and erythromycin.
CONCLUSION:
Infection is the most common reason for explantation after prosthetic breast reconstruction. Patients should be carefully monitored for a prolonged period of time after Stage I, as majority of the explantations occur in this stage but beyond 30 days. For oral treatment, fluoroquinolones and trimetoprim-sulfametoxazol and;
for IV treatment a combination of vancomycin or daptomycin with piperacillin-tazobactam or imipenems/carbapenems appear to be appropriate choices according to our culture and sensitivity results. METHODS. Twenty participants (average age 11.6 ± 2.27 years, 15 males) with surgically-treated NSC (10 sagittal (SSO), 5 right unilateral coronal (UCS), 5 metopic (MSO)) were individually matched to controls by age, gender, and handedness. Resting-state fMRI was acquired in a 3T Siemens TIM Trio scanner (Erlangen, Germany). Data was motion-corrected with SPM (University College London) and underwent CSF and WM signal regression. BioImage Suite (Yale School of Medicine) was then used to analyze whole-brain intrinsic connectivity as well as seed-based connectivity for Brodmann Areas (BA) 7, 39 and 40, which are areas of language and visuospatial integration that have been previously implicated. 3 Resulting group-level t-maps were cluster-corrected using nonparametric permutation tests with 5000 permutations in FSL (FMRIB, Oxford, UK).
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RESULTS:
SSO demonstrated decreased wholebrain intrinsic connectivity compared to controls in left BA-39 and bilateral BA-7's (p=0.071), which are the superior parietal lobules and the angular gyrus. UCS had significantly decreased intrinsic connectivity throughout the prefrontal cortex (PFC, p=0.031). On seed-based analysis, UCS had significantly increased connectivity between left BA-40 and bilateral BA-6, BA-8, and BA-9, and left BA-32 (p=0.050), between left BA-7 and the anterior PFC (p=0.065), and between left BA-7 and right BA-7 and BA-9 (p=0.077). MSO demonstrated increased connectivity between the left BA-7 seed and the right inferior frontal gyrus and right insula (p=0.090).
CONCLUSION:
NSC is associated with altered brain connectivity that varies by type of synostosis. SSO had decreased connectivity in regions of the parietal cortex associated with spatial cognition, visuomotor integration, and attention. UCS demonstrated significantly decreased intrinsic connectivity in the PFC, which plays a crucial role in executive function, as well as increased connectivity between the PFC and the right parietal cortex. Finally, MSO was the only group to demonstrate aberrations in the right insula and right inferior frontal gyrus. This study provides neurologic evidence of long-term sequelae of NSC that varies by suture type, which may underlie different phenotypes of neuropsychiatric impairment.
